文献速递糖尿病

糖尿病中心力衰竭的流行病学:一种被掩盖的疾病

Epidemiology of heart failure in diabetes: a disease in disguise.
PubMed 文献 · Diabetologia · 2024-02-09

该综述结合叙述性综述与系统评价,聚焦2型糖尿病中心力衰竭的诊断与流行病学。系统评价纳入57项研究及先前Meta分析中的29项,报告左心室舒张功能障碍患病率43%(95%CI 37%,50%)、射血分数保留的心力衰竭17%(95%CI 7%,35%)等,并指出诊断标准异质性限制证据。

要点

  • 2型糖尿病中无症状左心室舒张功能障碍和射血分数保留的心力衰竭是最常见表型。
  • 系统评价报告左心室舒张功能障碍患病率43%(95%CI 37%,50%),射血分数保留的心力衰竭17%(95%CI 7%,35%)。
  • 射血分数保留的心力衰竭发生率7%(95%CI 4%,11%)高于射血分数降低的心力衰竭4%(95%CI 3%,7%)。

核心结论

  • 系统评价部分为2型糖尿病中心力衰竭的患病率/发生率提供了新见解,揭示了大量存在左心室舒张功能障碍/射血分数保留的心力衰竭的临床前目标人群,早期识别和治疗可能阻止疾病进展。

研究设计与样本

  • 采用叙述性综述与系统评价相结合的方法,叙述性部分聚焦2型糖尿病中心力衰竭的诊断(依据2021年欧洲心脏病学会指南)和筛查。
  • 系统评价检索Embase和MEDLINE数据库(2016年至2022年10月),纳入报告≥18岁2型糖尿病成人经超声心动图数据的心力衰竭亚型患病率和发生率的研究。
  • 从5015项研究中筛选209篇全文,最终纳入57项研究,并结合先前Meta分析中识别的29项研究。
  • 纳入研究报告左心室收缩功能障碍(25项研究,24460人)、左心室舒张功能障碍(65项研究,25729人)、射血分数降低的心力衰竭(4项研究,4090人)、射血分数轻度降低的心力衰竭(2项研究,2442人)和/或射血分数保留的心力衰竭(8项研究,5292人)的患病率,以及心力衰竭发生率(7项研究,17935人)。
  • 使用Hoy等偏倚风险工具评估,纳入研究总体具有高偏倚风险;采用随机效应Meta分析,结果以森林图呈现;注册号PROSPERO ID CRD42022368035。

主要发现

  • 左心室舒张功能障碍患病率43%(95%CI 37%,50%),射血分数保留的心力衰竭17%(95%CI 7%,35%),左心室收缩功能障碍6%(95%CI 3%,10%),射血分数降低的心力衰竭7%(95%CI 3%,15%),射血分数轻度降低的心力衰竭12%(95%CI 7%,22%)。
  • 左心室舒张功能障碍中以I级最为常见。
  • 射血分数保留的心力衰竭发生率7%(95%CI 4%,11%),高于射血分数降低的心力衰竭4%(95%CI 3%,7%)。

关键数值与推荐

  • 叙述性部分采用2021年欧洲心脏病学会指南讨论2型糖尿病中心力衰竭的诊断与筛查。
  • 系统评价采用随机效应Meta分析,结果以森林图呈现,并使用Hoy等偏倚风险工具评估纳入研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据受多年来诊断标准异质性限制。
  • 使用Hoy等偏倚风险工具发现纳入研究总体具有高偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Left ventricular diastolic dysfunction (LVDD) without symptoms, and heart failure (HF) with preserved ejection fraction (HFpEF) represent the most common phenotypes of HF in individuals with type 2 diabetes mellitus, and are more common than HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction (HFmrEF) and left ventricular systolic dysfunction (LVSD) in these individuals. However, diagnostic criteria for HF have changed over the years, resulting in heterogeneity in the prevalence/incidence rates reported in different studies. We aimed to give an overview of the diagnosis and epidemiology of HF in type 2 diabetes, using both a narrative and systematic review approach; we focus narratively on diagnosing (using the 2021 European Society of Cardiology [ESC] guidelines) and screening for HF in type 2 diabetes. We performed an updated (2016-October 2022) systematic review and meta-analysis of studies reporting the prevalence and incidence of HF subtypes in adults ≥18 years with type 2 diabetes, using echocardiographic data. Embase and MEDLINE databases were searched and data were assessed using random-effects meta-analyses, with findings presented as forest plots. From the 5015 studies found, 209 were screened using the full-text article. In total, 57 studies were included, together with 29 studies that were identified in a prior meta-analysis; these studies reported on the prevalence of LVSD (n=25 studies, 24,460 individuals), LVDD (n=65 studies, 25,729 individuals), HFrEF (n=4 studies, 4090 individuals), HFmrEF (n=2 studies, 2442 individuals) and/or HFpEF (n=8 studies, 5292 individuals), and on HF incidence (n=7 studies, 17,935 individuals). Using Hoy et al's risk-of-bias tool, we found that the studies included generally had a high risk of bias. They showed a prevalence of 43% (95% CI 37%, 50%) for LVDD, 17% (95% CI 7%, 35%) for HFpEF, 6% (95% CI 3%, 10%) for LVSD, 7% (95% CI 3%, 15%) for HFrEF, and 12% (95% CI 7%, 22%) for HFmrEF. For LVDD, grade I was found to be most prevalent. Additionally, we reported a higher incidence rate of HFpEF (7% [95% CI 4%, 11%]) than HFrEF 4% [95% CI 3%, 7%]). The evidence is limited by the heterogeneity of the diagnostic criteria over the years. The systematic section of this review provides new insights on the prevalence/incidence of HF in type 2 diabetes, unveiling a large pre-clinical target group with LVDD/HFpEF in which disease progression could be halted by early recognition and treatment.Registration PROSPERO ID CRD42022368035.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hoek AG, Dal Canto E, Wenker E, et al. Epidemiology of heart failure in diabetes: a disease in disguise. Diabetologia. 2024. PMID: 38334818. doi:10.1007/s00125-023-06068-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。